TipHub

39

-1.42 -3.51%

30 Jul 2026

BSE Listed

ESM · ESM 1
What does ESM · ESM 1 mean?
BSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-04-23

Sudarshan Pharma Industries Ltd. (543828)

Volume: 1,28,000Avg Vol 1W: 3,26,400Avg Vol 1M: 3,65,45552W Range:18.542.79
Market Cap₹939 Cr
Current Price₹39
Previous Close₹40.42
High / Low (52w)₹42.79 / ₹18.5
Volume1,28,000
Avg Vol (1W)3,26,400
Avg Vol (1M)3,65,455
Stock P/E40.21
Book Value₹6.44
Dividend Yield0%
ROE15.03%
ROA364.16%
Revenue (TTM)
Revenue Growth
Profit Margin331.55%
Total Debt
Shares Outstanding24 Cr
Face Value
EPS (TTM)₹0.97
P/B6.05
Debt / Equity1.13
50 DMA₹37.84
200 DMA₹28.96
Day change-3.51%
SurveillanceESM · ESM 1
Price Chart
39 44.50% · 1Y
891920.1L
2025-07-30
2026-07-30

20-day avg volume: 4.0L shares

Pros
  • Healthy return on equity of 15.0%.
  • Company is almost debt-free.
  • Revenue grew 26% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹99 Cr₹129 Cr₹116 Cr₹162 Cr₹145 Cr₹169 Cr₹168 Cr₹221 Cr
EBITDA₹2 Cr₹13 Cr₹8 Cr₹16 Cr₹11 Cr₹10 Cr₹11 Cr₹23 Cr
Net Profit₹-1 Cr₹6 Cr₹3 Cr₹7 Cr₹4 Cr₹4 Cr₹4 Cr₹11 Cr
EPS
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹124 Cr₹116 Cr₹162 Cr₹508 Cr₹142 Cr₹167 Cr₹158 Cr₹200 Cr
EBITDA₹12 Cr₹8 Cr₹15 Cr₹40 Cr₹11 Cr₹11 Cr₹12 Cr₹21 Cr
Net Profit₹5 Cr₹3 Cr₹7 Cr₹16 Cr₹4 Cr₹4 Cr₹4 Cr₹10 Cr
EPS0.66
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹58 Cr₹99 Cr₹138 Cr₹232 Cr₹283 Cr₹402 Cr
Total Liabilities₹38 Cr₹77 Cr₹108 Cr₹132 Cr₹171 Cr₹271 Cr
Equity₹20 Cr₹23 Cr₹30 Cr₹101 Cr₹112 Cr₹131 Cr
Total Debt
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹1 Cr₹4 Cr₹-2 Cr₹-27 Cr₹8 Cr₹38 Cr
Investing₹-2 Cr₹-1 Cr₹-1 Cr₹-26 Cr₹-5 Cr₹-20 Cr
Financing₹0 Cr₹-1 Cr₹4 Cr₹66 Cr₹-12 Cr₹-14 Cr
Free Cash Flow₹1 Cr₹4 Cr₹-2 Cr₹-27 Cr₹8 Cr₹38 Cr
Shareholding
Promoter 58.93% Institutions 19.38% Public 21.69%
Efficiency & Working Capital
ROCE12.8%
Interest Coverage2.6
Dividend Payout
Debtor Days116 d
Inventory Days102 d
Payable Days66 d
Cash Conversion Cycle151 d
Working Capital Days217 d
Shareholding Details

As of 2026-06-30

Promoter58.9%
FII19.4%
DII0%
Institutions19.4%
Public21.7%
Promoter Pledge1.4%
No. of Shareholders1,231
Shareholding Pattern

Quarterly — figures in %. Latest 10 quarters.

PeriodMar 2023Sept 2023Mar 2024Sept 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters57.4%57.4%57.4%57.4%57.4%57.4%57.4%57.4%57.4%58.9%
FIIs3.6%1.4%1.4%13.1%18.5%19.5%20.8%19.8%19.9%19.4%
DIIs0%0%0%0%0%0%0%0%0%0%
Public39%41.2%41.2%29.5%24.2%23.1%21.8%22.8%22.7%21.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%1.4%
No. of Shareholders1,2449839137871,2121,3271,3831,4071,3461,231
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Sachin Vasantrai MehtaShareholding of Promoter and Promoter Group28.3%7.07 Cr
Hemal Vasantrai MehtaShareholding of Promoter and Promoter Group27.5%6.85 Cr
Multitude Growth Funds LimitedPublic Shareholding4.7%1.17 Cr
Century India Opportunity Fund PcPublic Shareholding3.2%81,00,000
Eminence Global Fund Pcc- Eubilia Capital PartnersPublic Shareholding2%48,56,000
Ebisu Global Opportunities Fund LimitedPublic Shareholding1.9%48,00,000
Nexpact LimitedPublic Shareholding1.8%45,68,000
Coeus Global Opportunities FundPublic Shareholding1.7%41,96,000
North Star Opportunities Fund Vcc-bull Value IncorPublic Shareholding1.7%41,12,000
Saumik Ketankumar DoshiPublic Shareholding1.6%40,36,000
Bridge India FundPublic Shareholding1.6%39,80,000
Devangi Hemal MehtaShareholding of Promoter and Promoter Group0.9%22,94,070
Namrata Sachin MehtaShareholding of Promoter and Promoter Group0.7%16,45,120
Hemal V Mehta Huf .Shareholding of Promoter and Promoter Group0.7%16,45,120
Sachin V Mehta Huf .Shareholding of Promoter and Promoter Group0.7%16,45,120
Vasantray Ratilal MehtaShareholding of Promoter and Promoter Group0.2%4,93,190
Jatin Vasantrai MehtaShareholding of Promoter and Promoter Group0.1%1,64,470
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Hemal Vasantrai Mehta20,00,0002.9%2026-06-30
Board of Directors
NameDesignationYear
Hemal V MehtaCMD & Director.2025
Sachin V MehtaED / Joint MD / CFO / Promoter2025
Umesh LuthraIndependent Non Exe. Director2025
JAYA ANKUR SINGHANIAIndependent Non Exe. Director2025
Rushabh Prashant PatilIndependent Non Exe. Director2025
ANIL BALKRISHNA GHOGARENon-Exec & Non-Independent Dir2025
NIRAV KISHOR KUMAR SHAHCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Chemical Division₹96 Cr68.7%
Pharmaceutical Division₹43 Cr31.3%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1352424
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025120052138
20254004412
20253002914
Company Information
Incorporated2008
ChairmanHemal V Mehta
AuditorNGST & Associates
Investor Email[email protected]
🌐 www.sudarshanpharma.com

📍 301 3rd Floor Aura Biplex, SV Road Borivali(West), Mumbai, Maharashtra, 400092

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search